Published in Blood Weekly, November 11th, 2004
A cross-licensing arrangement of the respective companies' selected intellectual property rights is also a part of the agreements. The products subject to these agreements will be marketed by ELANA for use in bypass surgery, initially focused on neurovascular applications.
ELANA (excimer laser-assisted non-occlusive anastomosis) is the only known surgical technique that enables surgeons to create a bypass without occluding the recipient vessel,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.